Iterum Therapeutics PLC (ITRM)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-12-27 | 2023-12-22 | B Purchase | Non-Executive Director |
25,000
+28.2%
1.40USD 35,000 |
25,000 +28.2% | 1.40 | USD 35,000 | |
| 2023-12-19 | 2023-12-18 | B Purchase | Non-Executive Director |
10,000
+12.7%
1.84USD 18,442 |
10,000 +12.7% | 1.84 | USD 18,442 | |
| 2023-11-27 | 2023-11-22 | B Purchase | Non-Executive Director |
20,000
+34.0%
2.03USD 40,690 |
20,000 +34.0% | 2.03 | USD 40,690 | |
| 2023-11-20 | 2023-11-20 | B Purchase |
Chief Executive Officer Executive Director |
10,000
+22.5%
1.59USD 15,863 |
10,000 +22.5% | 1.59 | USD 15,863 | |
| 2022-12-05 | 2022-12-02 | S Sale |
Chief Medical Officer Officer |
3,365
-40.4%
1.32USD 4,442 |
3,365 -40.4% | 1.32 | USD 4,442 | |
| 2022-09-20 | 2022-09-20 | S Sale | Non-Executive Director |
7,246
-100.0%
1.78USD 12,910 |
7,246 -100.0% | 1.78 | USD 12,910 | |
| 2022-09-20 | 2022-09-19 | S Sale | Non-Executive Director |
15,000
-67.4%
1.77USD 26,478 |
15,000 -67.4% | 1.77 | USD 26,478 | |
| 2022-09-20 | 2022-09-16 | S Sale | Non-Executive Director |
15,000
-40.3%
1.90USD 28,542 |
15,000 -40.3% | 1.90 | USD 28,542 | |
| 2022-09-15 | 2022-09-15 | S Sale | Non-Executive Director |
15,000
-28.7%
2.02USD 30,272 |
15,000 -28.7% | 2.02 | USD 30,272 | |
| 2022-09-15 | 2022-09-14 | S Sale | Non-Executive Director |
15,000
-22.3%
2.10USD 31,457 |
15,000 -22.3% | 2.10 | USD 31,457 | |
| 2022-09-15 | 2022-09-13 | S Sale | Non-Executive Director |
15,000
-18.2%
2.14USD 32,118 |
15,000 -18.2% | 2.14 | USD 32,118 | |
| 2022-09-12 | 2022-09-12 | S Sale | Non-Executive Director |
15,000
-15.4%
2.31USD 34,608 |
15,000 -15.4% | 2.31 | USD 34,608 | |
| 2022-09-12 | 2022-09-09 | S Sale | Non-Executive Director |
15,000
-13.4%
2.32USD 34,730 |
15,000 -13.4% | 2.32 | USD 34,730 | |
| 2022-09-12 | 2022-09-08 | S Sale | Non-Executive Director |
3,298
-2.9%
2.26USD 7,465 |
3,298 -2.9% | 2.26 | USD 7,465 | |
| 2022-09-09 | 2022-09-07 | B Purchase | Non-Executive Director |
10,000
+39.1%
2.22USD 22,200 |
10,000 +39.1% | 2.22 | USD 22,200 | |
| 2022-03-15 | 2022-03-14 | S Sale |
Chief Financial Officer Officer |
47,132
-36.6%
0.38USD 17,910 |
47,132 -36.6% | 0.38 | USD 17,910 | |
| 2021-02-12 | 2021-02-12 | S Sale | Large shareholder |
10,619,949
-100.0%
2.27USD 24,107,284 |
10,619,949 -100.0% | 2.27 | USD 24,107,284 | |
| 2021-02-12 | 2021-02-11 | S Sale | Large shareholder |
10,000,000
-48.5%
2.59USD 25,900,000 |
10,000,000 -48.5% | 2.59 | USD 25,900,000 | |
| 2021-01-27 | 2021-01-26 | S Sale |
President & CEO Executive Director |
85,445
-21.0%
1.73USD 147,820 |
85,445 -21.0% | 1.73 | USD 147,820 | |
| 2021-01-27 | 2021-01-26 | S Sale | Non-Executive Director |
33,143
-11.4%
1.73USD 57,337 |
33,143 -11.4% | 1.73 | USD 57,337 | |
| 2021-01-27 | 2021-01-26 | S Sale |
Chief Financial Officer Officer |
33,868
-54.2%
1.73USD 58,592 |
33,868 -54.2% | 1.73 | USD 58,592 | |
| 2020-10-28 | 2020-10-27 | B Purchase |
Chief Scientific Officer Officer |
61,540
0.00USD 0 |
61,540 | 0.00 | USD 0 | |
| 2020-10-02 | 2020-09-30 | PS Planned sale |
Chief Financial Officer Officer |
56,130
-100.0%
1.64USD 92,053 |
56,130 -100.0% | 1.64 | USD 92,053 | |
| 2020-06-03 | 2020-06-02 | S Sale |
Sofinnova Venture Partners IX, L.P. Large shareholder |
400,000
-24.6%
1.61USD 642,960 |
400,000 -24.6% | 1.61 | USD 642,960 | |
| 2020-06-03 | 2020-06-01 | S Sale |
Sofinnova Venture Partners IX, L.P. Large shareholder |
100,000
-5.8%
1.69USD 169,120 |
100,000 -5.8% | 1.69 | USD 169,120 | |
| 2018-12-04 | 2018-11-30 | B Purchase |
Kelly David George Non-Executive Director |
10,000
+104.7%
6.29USD 62,887 |
10,000 +104.7% | 6.29 | USD 62,887 | |
| 2018-11-01 | 2018-10-30 | B Purchase |
Chin Mark Non-Executive Director |
58,000
+5.6%
6.10USD 353,800 |
58,000 +5.6% | 6.10 | USD 353,800 | |
| 2018-09-06 | 2018-09-04 | B Purchase |
Dunne Michael W. Chief Scientific Officer Officer |
500
+0.3%
10.00USD 5,000 |
500 +0.3% | 10.00 | USD 5,000 | |
| 2018-08-28 | 2018-08-27 | B Purchase |
Dunne Michael W. Chief Scientific Officer Officer |
500
+0.3%
10.00USD 5,000 |
500 +0.3% | 10.00 | USD 5,000 | |
| 2018-08-28 | 2018-08-24 | B Purchase |
Dunne Michael W. Chief Scientific Officer Officer |
500
+0.3%
10.00USD 5,000 |
500 +0.3% | 10.00 | USD 5,000 | |
| 2018-08-27 | 2018-08-23 | B Purchase |
Edick Paul R Non-Executive Director |
500
+2.0%
10.44USD 5,219 |
500 +2.0% | 10.44 | USD 5,219 | |
| 2018-08-21 | 2018-08-17 | B Purchase |
Fishman Corey N. President & CEO Executive Director |
2,000
+0.8%
8.73USD 17,466 |
2,000 +0.8% | 8.73 | USD 17,466 | |
| 2018-06-01 | 2018-05-30 | B Purchase |
Chin Mark Non-Executive Director |
337,606
+48.6%
13.00USD 4,388,878 |
337,606 +48.6% | 13.00 | USD 4,388,878 | |
| 2018-05-31 | 2018-05-30 | B Purchase |
Lathi Vijay K Large shareholder |
384,615
+inf%
13.00USD 4,999,995 |
384,615 +inf% | 13.00 | USD 4,999,995 | |
| 2018-05-31 | 2018-05-30 | B Purchase |
Lathi Vijay K Large shareholder |
278,062
+35.0%
13.00USD 3,614,806 |
278,062 +35.0% | 13.00 | USD 3,614,806 | |
| 2018-05-31 | 2018-05-30 | B Purchase |
HUNT RONALD Non-Executive Director Large shareholder |
384,615
+inf%
13.00USD 4,999,995 |
384,615 +inf% | 13.00 | USD 4,999,995 | |
| 2018-05-31 | 2018-05-30 | B Purchase |
HUNT RONALD Non-Executive Director Large shareholder |
278,062
+35.0%
13.00USD 3,614,806 |
278,062 +35.0% | 13.00 | USD 3,614,806 | |
| 2018-05-30 | 2018-05-30 | B Purchase |
Fishman Corey N. President & CEO Executive Director |
3,000
+1.3%
13.00USD 39,000 |
3,000 +1.3% | 13.00 | USD 39,000 | |
| 2018-05-30 | 2018-05-30 | B Purchase |
CANAAN X L.P. Non-Executive Director Large shareholder |
506,656
+41.3%
13.00USD 6,586,528 |
506,656 +41.3% | 13.00 | USD 6,586,528 | |
| 2018-05-30 | 2018-05-30 | B Purchase |
Matthews Judith M. Chief Financial Officer Officer |
4,000
+7.7%
13.00USD 52,000 |
4,000 +7.7% | 13.00 | USD 52,000 | |
| 2018-05-30 | 2018-05-30 | B Purchase |
Ahrens Brenton Karl Non-Executive Director |
506,656
+41.3%
13.00USD 6,586,528 |
506,656 +41.3% | 13.00 | USD 6,586,528 | |
| 2018-05-30 | 2018-05-30 | B Purchase |
Malik Shahzad Non-Executive Director |
228,840
+37.5%
13.00USD 2,974,920 |
228,840 +37.5% | 13.00 | USD 2,974,920 | |
| 2018-05-30 | 2018-05-30 | B Purchase |
Malik Shahzad Non-Executive Director |
8,144
+37.5%
13.00USD 105,872 |
8,144 +37.5% | 13.00 | USD 105,872 | |
| 2018-05-30 | 2018-05-30 | B Purchase |
Heron Patrick J Non-Executive Director Large shareholder |
101,150
+42.1%
13.00USD 1,314,950 |
101,150 +42.1% | 13.00 | USD 1,314,950 | |
| 2018-05-30 | 2018-05-30 | B Purchase |
Heron Patrick J Non-Executive Director Large shareholder |
354,949
+42.1%
13.00USD 4,614,337 |
354,949 +42.1% | 13.00 | USD 4,614,337 | |
| 2018-05-30 | 2018-05-30 | B Purchase |
Dunne Michael W. Chief Scientific Officer Officer |
2,000
+1.4%
13.00USD 26,000 |
2,000 +1.4% | 13.00 | USD 26,000 | |
| 2018-05-30 | 2018-05-30 | B Purchase |
HEALY JAMES Non-Executive Director Large shareholder |
500,000
+40.8%
13.00USD 6,500,000 |
500,000 +40.8% | 13.00 | USD 6,500,000 | |
| 2018-05-30 | 2018-05-30 | B Purchase |
Sofinnova Venture Partners IX, L.P. Large shareholder |
500,000
+40.8%
13.00USD 6,500,000 |
500,000 +40.8% | 13.00 | USD 6,500,000 |